JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2004; 44:528-537, doi:10.1016/j.jacc.2004.03.077
© 2004 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Serruys, P. W.
Right arrow Articles by van der Giessen, W. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Serruys, P. W.
Right arrow Articles by van der Giessen, W. J.

Direct stenting versus direct stenting followed by centered beta-radiation with intravascular ultrasound-guided dosimetry and long-term anti-platelet treatment

Results of a randomized trial: Beta-radiation Investigation with Direct stenting and Galileo in Europe (BRIDGE)

Patrick W. Serruys, MD, PhD, FACC*,*, William Wijns, MD{dagger}, Georgios Sianos, MD, PhD*, Ivan de Scheerder, MD{ddagger}, Paul A. van den Heuvel, MD§, Wolfgang Rutsch, MD||, Helmut D. Glogar, MD, Carlos Macaya, MD#, Pierre H. Materne, MD**, Susan Veldhof, RN{dagger}{dagger}, Heike Vonhausen, PhD{dagger}{dagger}, Patricia C. Otto-Terlouw, MSc{ddagger}{ddagger} and Wim J. van der Giessen, MD, PhD*

* Erasmus Medical Center, Rotterdam, The Netherlands
{dagger} Onze Lieve Vrouw Ziekenhuis, Aalst, Belgium
{ddagger} UZ Gasthuisberg, Leuven, Belgium
§ Academisch Ziekenhuis Middelheim, Antwerpen, Belgium
|| Universitätsklinik Charité, Berlin, Germany
Allgemeines Krankenhaus der Stadt, Wien, Austria
# Hospital Clínico San Carlos, Madrid, Spain
** CHR de la Citadelle, Liege, Belgium
{dagger}{dagger} Guidant, Diegem, Belgium
{ddagger}{ddagger} Cardialysis BV, Rotterdam, The Netherlands



View larger version (48K):

[in a new window]
 
Figure 1 A schematic diagram of the tandem positioning of the 32P radiation source and an irradiated coronary artery with the anatomical and dose-based sub-segment definition. BRM = balloon radiopaque marker; CB = centering balloon; CBRM = centering balloon radiopaque marker; EIRL = effective irradiation length; EIRS = effective irradiated segment; INS = injured segment; IRL = irradiation length; IRS = irradiated segment; SB = side branch; SL = stent length; SrL = source length; SrRM = source radiopaque marker; VS = vessel segment.

 


View larger version (21K):

[in a new window]
 
Figure 4 Event-free survival curves (Kaplan-Meier) at one year for the control and irradiated patients. MACE = major adverse cardiac and cerebrovascular events; p(FE) = p value Fisher exact test; p(LR) = p value log rank test; RR = relative risk.

 


View larger version (72K):

[in a new window]
 
Figure 2 An example of quantitative coronary angiography depicting the automatic assessment of the anatomic relationship between the obstructed (A), the injured (B), and the irradiated (C) sub-segments, which allows the quantitative assessment of the length of the geographical miss, 8.73 mm at the proximal edge in this case.

 


View larger version (24K):

[in a new window]
 
Figure 3 Location of the minimal luminal diameter at six months follow-up (±4 weeks) in patients with >50% diameter stenoses in relation to the dose-based sub-segments. Four instances of late total occlusion (LTO) were documented at the time of the angiographic follow-up, and two occurred later. EIRS = effective irradiated segment; IRS = irradiated segment; VS = vessel segment.

 





HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2004 by the American College of Cardiology Foundation.